Biology and management of AIDS-associated non-Hodgkin's lymphoma

Amy E Gates; Lawrence D Kaplan

doi:10.1016/s0889-8588(03)00041-8

Biology and management of AIDS-associated non-Hodgkin's lymphoma

Hematol Oncol Clin North Am. 2003 Jun;17(3):821-41. doi: 10.1016/s0889-8588(03)00041-8.

Authors

Amy E Gates¹, Lawrence D Kaplan

Affiliation

¹ Positive Health Program, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA 94110, USA. agates@php.ucsf.edu

PMID: 12852657
DOI: 10.1016/s0889-8588(03)00041-8

Abstract

The treatment of HIV-related lymphomas is evolving in the era of HAART. Standard-dose chemotherapy and dose-intensive therapies appear to be feasible. Whether outcomes are improved with combination chemotherapy and HAART remains unclear. Efforts aimed at developing pathogenic-based therapies will continue as the mechanisms of HIV lymphomagenesis are elucidated.

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Antiretroviral Therapy, Highly Active
Disease Management
Humans
Lymphoma, AIDS-Related / classification
Lymphoma, AIDS-Related / drug therapy*
Lymphoma, AIDS-Related / etiology*
Lymphoma, Non-Hodgkin
Salvage Therapy